Treatment Information

Back

Ovarian Cancer treatment details. Chemotherapy.

M.D. Anderson Cancer Center Orlando, Orlando, FL, United States.

Survival: monthsCountry:United States
Toxiciy Grade:5City/State/Province:Orlando, FL
Treatments:ChemotherapyHospital:M.D. Anderson Cancer Center Orlando
Drugs:Journal:Link
Date:Dec 2011

Description:

Patients:
This phase III study involved women with ovarian cancer who were divided into two separate treatment groups. Group A consisted of 417 patients with a median age of 60 years. Group B had 414 patients with a median age of 60 years.

Treatment:
Patients in Group A were treated with the chemotherapy agents gemcitabine and carboplatin.
Patients in Group B were treated with the chemotherapy agents paclitaxel and carboplatin.

Toxicities:
There were 2 deaths in Group A due to infection and respiratory failure. In addition, 80.6% of patients had grade 3-4 neutropenia, 40% had grade 3-4 thrombocytopenia, and 27.4 % had grade 3-4 anemia.

There were 3 deaths in Group B due to infection, pneumonia, and pulmonary embolism. In addition, 78.7% of patients had grade 3-4 neutropenia and 51% had grade 2 or higher alopecia.

Results:
The median overall survival rates for groups A and B were 43.8 and 57.3 months, respectively.

Support:
This study was supported by the pharmaceutical company Eli Lilly.

Correspondence: Dr. Alan N. Gordon; email: agordonmd@mac.com



Back